HER2 Ultralow Detection

About Lumito

Lumito is a pioneering diagnostics company commercializing a novel tissue imaging platform centered on upconverting nanoparticles (UCNPs), which offer ultra-sensitive detection without autofluorescence. Its core product, the SCIZYS system, enables high-accuracy quantification of biomarkers, targeting critical needs in precision oncology (e.g., HER2 low/ultralow expression) and translational research. The company is transitioning from development to early commercial engagements, leveraging a scalable 'Scan-as-a-Service' model and strategic partnerships to penetrate the growing digital pathology market.

Therapeutic Areas